Leader in Health Management Technology Sees Continued Adoption, Announces Funding
Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing it has secured growth capital led by Refinery Ventures, with participation from repeat investors MCP, Rev1 Ventures, and M25. The funding follows the company’s recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.
“Redi.Health aligns with our mission in developing companies that change the way we see the world,” said Tim Schigel, Managing Partner at Refinery Ventures. “Technology is revolutionizing healthcare, which is an industry that is long overdue for innovation. Redi.Health is helping simplify an extremely complex industry so patients can take more control of their healthcare journey. We understand how vital it is for outcomes and look forward to working with the Redi.Health team through its next phase of growth.”
Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface. The company has integrated a more robust data algorithm that allows Redi.Health to simultaneously connect patients to support offered by healthcare stakeholders while providing insights to those stakeholders to ensure the right support is getting to the right patient at the right time.
“For patients managing chronic conditions, access to information and support about medications, symptoms, wellness tips and more is critical,” said Luke Buchanan, Co-Founder, and CEO at Redi.Health. “We are dedicated to delivering a truly patient-centric model that improves quality of life, and we know we’re filling an obvious need for the market and patient community. Our growth confirms it.”
Redi.Health recently forged partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp Drug Development Patient Access Solutions with Redi.Health’s digital support platform to more seamlessly connect patients and providers.
The company expects to continue to accelerate in 2023 with more advancements for improved patient outcomes. For more information about Redi.Health’s groundbreaking approach, visit https://www.redi.health/.
About Redi.Health
Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support. Combining health management technology and pharmaceutical manufacturer support into one tool, Redi.Health provides a mobile platform that allows patients to manage everything from multiple medications and symptoms to diet and exercise. By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.
Originally announced October 17th, 2022
